Leaderboard

Fr | De
Feedback | Impressum | Sitemap
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie 18. Mars 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Œsophage
Troubles de la motilité
Néoplasie
Autres
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 1924  Page précédente Page suivante
   
   Articles 1 - 20 / 38473  
   
Epidemiology of Risk Stratification, Machine Learning Early Prediction Model, and Tumor Suppressive Mechanism of RHBDF2 in Esophageal Cancer in Gansu Province.
Cancer Med
Zhu D, Che Y, Cheng H, Wang W, Li Y.
PMID: 41846261 [PubMed - indexed for MEDLINE]

NY-ESO-1 in Triple-Negative Breast Cancer: Systematic Review, Meta-Analysis, and Immunotherapeutic Implications.
Int Immunopharmacol
Nik Amirah Auni NMA, Mohd Redzwan N, Hussain FA, Yahya MM, Ab Hamid SS, Wong KK.
PMID: 41846058 [PubMed - as supplied by publisher]

Clinical role of anti-PD-1 immunotherapies in esophageal cancer.
Expert Rev Gastroenterol Hepatol
Sano M, Imazeki H, Yamamoto S, Kato K.
PMID: 41842748 [PubMed - as supplied by publisher]

Disease Self-Monitoring Behaviors and Influencing Factors Among Family Members of Patients With Digestive Tract Cancer: A Latent Profile Analysis.
Psychooncology
Zhou L, Yang L, Zhu X, Han Y, Yang L, Li K.
PMID: 41839757 [PubMed - indexed for MEDLINE]

Anti-Hu paraneoplastic syndrome with gastrointestinal dysmotility associated with nasopharyngeal squamous cell carcinoma and small bowel adenocarcinoma.
BMJ Case Rep
Chen JN, Leung ECH, Jiang K, Cunningham JM.
PMID: 41839521 [PubMed - indexed for MEDLINE]

Comparative analysis of early-onset and late-onset esophageal cancer burden in China, 1990-2021: based on the 2021 Global Burden of Disease Study.
Esophagus
Zhang Z, Gong Y, Liu L, Zhu Y, Zhou J, Zhu X.
PMID: 41838257 [PubMed - as supplied by publisher]

Metformin Use and Development of Esophageal Squamous Cell Carcinoma.
JAMA Netw Open
Xie SH, Santoni G, Birgisson H, von Euler-Chelpin M, Kauppila JH, Ness-Jensen E, Lagergren J.
PMID: 41837999 [PubMed - indexed for MEDLINE]

Efficacy and safety of neoadjuvant immunotherapy in locally advanced resectable esophageal squamous cell carcinoma: a network meta-analysis and real-world study.
Front Immunol
Sun M, Yang P, Qi L, Yang T, Wang W, Yu Y, Zhang J, Zhu B, Li Y.
PMID: 41836437 [PubMed - indexed for MEDLINE]

Sex-based heterogeneity in response to first-line immunotherapy plus chemotherapy in advanced esophageal squamous-cell carcinoma: a meta-analysis.
Front Immunol
Yang K, Shang W, Wang L, He J, Zuo Z, Dai Q, Liu J, Zeng L, Yang Y, Cao F, Yu Y, Wan G.
PMID: 41836421 [PubMed - indexed for MEDLINE]

Surgical treatment of the patient with locally advanced esophageal cancer and concurrent thymoma after neoadjuvant therapy: a case report.
Front Immunol
Zhang QX, Liu H, Xu J, Zeng T, Zhang J, Ren XF, Li D, Guo Q, Liu T.
PMID: 41836409 [PubMed - indexed for MEDLINE]

A combined immune-nutritional score as a prognostic indicator in neoadjuvant-treated esophageal squamous cell carcinoma.
Front Immunol
Xie Q, Zhan J, Ye X, Huang C, Chen C, Zheng B, Xu G, Yang Z, Zhu Y.
PMID: 41836385 [PubMed - indexed for MEDLINE]

Study on the network of postoperative symptoms and its influencing factors in esophageal cancer patients.
Front Oncol
Zhao J, Liu Y, Xiao B, Tan T, Yin Y, Hu Y, Li L.
PMID: 41836233 [PubMed]

Mutant p53 and TP53 mutations in esophageal squamous cell carcinoma: consistency and diagnostic significance.
Front Genet
Zhuang X, Lin N, Xu Y.
PMID: 41836060 [PubMed]

Menopausal hormone therapy and risk of esophageal and gastric cancer in a multi-national study.
J Natl Cancer Inst
Wocalewski V, Santoni G, Birgisson H, Von Euler-Chelpin M, Kauppila JH, Ness-Jensen E, Xie S, Lagergren J.
PMID: 41834112 [PubMed - as supplied by publisher]

Cancer Stem Cells in Esophageal Squamous Cell Carcinoma: A Path to Understanding.
Curr Stem Cell Res Ther
Singhal D, Saini M, Ghosal S, Sengupta U, Bhaumik C, Kashyap M, Krishnia L, Kashyap MK.
PMID: 41830565 [PubMed - as supplied by publisher]

Neoadjuvant Therapy for Esophageal Cancer.
Cancers (Basel)
Samadzadeh Tabrizi N, Marthy A, Fabian T.
PMID: 41827686 [PubMed]

Advanced imaging (narrow band and acetic acid chromoendoscopy) and guided biopsies in surveillance of Barrett's oesophagus: a systematic review.
BMJ Open Gastroenterol
Gamakaranage C, Butler TD, Ratcliffe E, Britton J, Keld R, Prasad N, Hamdy S, McLaughlin J, Ang Y.
PMID: 41825912 [PubMed - indexed for MEDLINE]

Dietary fat consumption and cancer outcomes: An umbrella review of systematic reviews and meta-analyses.
Am J Clin Nutr
Fan B, Zhang Z, Zhang Y, Guo Q, Chen P, Jian L, Pang L, Wu Y, Wang S.
PMID: 41825531 [PubMed - as supplied by publisher]

CT imaging is a feasible method for the preoperative prediction of the main pathologic response after neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma.
Updates Surg
Zhou H, Wei WW, Lin JP, Gao PQ, He H, Liu SY, Wang F.
PMID: 41824274 [PubMed - as supplied by publisher]

Real-world experience with first-line pembrolizumab plus chemotherapy in Vietnamese patients with stage IV esophageal squamous cell carcinoma.
Front Immunol
Van Tran T, Nguyen PT, Van Le Q, Nguyen GHT, Le Trinh H, Le KH, Hoang GN.
PMID: 41822478 [PubMed - indexed for MEDLINE]

   
   Articles 1 - 20 / 38473    Page 1 de 1924  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 
  Intervalle de temps demandé  
   

Sky right 1
Mediscope AG  E-mail: info@mediscope.ch 
Disclaimer | Privacy Policy | Publicité